Back to Journals » Clinical Ophthalmology » Volume 18

Enhancing OCT Reliability: The Role of Eye-Tracking in Achieving Consistent Retinal Measurements [Letter]

Authors Galvan J , Sousa LICGD , Guerra RLL

Received 31 October 2024

Accepted for publication 5 November 2024

Published 12 November 2024 Volume 2024:18 Pages 3237—3238

DOI https://doi.org/10.2147/OPTH.S503948

Checked for plagiarism Yes

Editor who approved publication: Dr Scott Fraser



Jessica Galvan,1 Leissa Iorranne Costa Gil de Sousa,1 Ricardo Luz Leitão Guerra1,2

1Leitão Guerra – Oftalmologia, Salvador, BA, Brazil; 2Orbit Ophthalmo Learning, São Paulo, SP Brazil

Correspondence: Jessica Galvan, Leitão Guerra – Oftalmologia, Rua Rio de São Pedro, 256 – Graça, Salvador, BA, 40150-350, Brazil, Tel +55 51 996863653, Fax +55 71 35256555, Email [email protected]


View the original paper by Dr Firdaus and colleagues

A Response to Letter has been published for this article.


Dear editor

We read with great interest the recent study by Firdaus et al1, which highlights the reproducibility of optical coherence tomography (OCT) measurements across two different Cirrus HD-OCT models. Their findings provide valuable insights into intermachine reliability and underscore the robustness of ganglion cell–inner plexiform layer (GCIPL) measurements, which exhibited high interdevice reproducibility. However, we wish to raise a note of caution regarding the potential bias that may arise when OCT scans are performed on different devices without standardized positioning, particularly in the absence of eye-tracking functionality.

Eye-tracking technology, integrated into many OCT devices, plays a crucial role in ensuring that sequential scans are consistently aligned within the same retinal area. This technology uses infrared light to detect and monitor small eye movements, adjusting the position of each subsequent scan to match the reference image precisely. Consequently, it minimizes positional discrepancies that could lead to erroneous interpretations of structural changes. This function is particularly critical in longitudinal studies or clinical follow-ups, where precise overlay of OCT scans is necessary for accurate assessment of progression in conditions such as glaucoma and macular degeneration.2,3

In their study, Firdaus et al conducted scans on different OCT models without enabling eye-tracking, which led to slight variations in the regions scanned. While the authors successfully demonstrated interdevice reproducibility under these conditions, we believe that including eye-tracking would enhance accuracy in follow-up assessments. For optimal clinical application, we recommend performing an initial scan with eye-tracking enabled, followed by consistent use of this tool across all subsequent assessments on the same device. This approach would reduce potential biases from scan misalignment, thereby strengthening the reliability of comparative OCT data.

We commend the authors for their valuable contribution and emphasize the importance of eye-tracking as an essential consideration for the reproducibility and reliability of OCT follow-up scans.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Firdaus S, Pereira LF, Yang G, Huang-Link Y. Interocular symmetry and intermachine reproducibility of optic disc and macular parameters measured by two different models of optical coherence tomography. Clin Ophthalmol. 2024;18:2397–2406. doi:10.2147/OPTH.S465360

2. Vienola K, Braaf B, Sheehy C, et al. Real-time eye motion compensation for OCT imaging with tracking SLO. Biomed Opt Expr. 2012;3(11):2950–2963. doi:10.1364/BOE.3.002950

3. Lauermann J, Treder M, Heiduschka P, Clemens C, Eter N, Alten F. Impact of eye-tracking technology on OCT-angiography imaging quality in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2017;255:1535–1542. doi:10.1007/s00417-017-3684-z

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.